No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation

Transplantation

Volumn 81, Issue 8, 2006, Pages 1212-1215

  Courivaud, Cécile ^a,b,c   Ferrand, Christophe ^a,b,d   Deschamps, Marina ^a,b,d   Tiberghien, Pierre ^a,b,c,d   Chalopin, Jean Marc ^a,b,c   Duperrier, Anne ^a,b,d   Saas, Philippe ^a,b,d,e   Ducloux, Didier ^a,b,c,e  

^a INSERM   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c UNIVERSITY HOSPITAL OF BESANÇON   (France)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e HÔPITAL SAINT JACQUES   (France)

Author keywords

Atherosclerosis; Inflammation; Innate immunity

Indexed keywords

ASPARTIC ACID; C REACTIVE PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GLYCINE; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARD15 GENE; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; KIDNEY TRANSPLANTATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NOD2 GENE; PATHOGENESIS; PRIORITY JOURNAL; RECIPIENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ATHEROSCLEROSIS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4;

EID: 33646814356     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000202846.17619.a4     Document Type: Article

References (20)

1. Kasiske BL, Guijarro C, Massy Z, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158.
2. Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptative immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91: 281.
3. Ducloux D, Kazory A, Chalopin JM. Post-transplant diabetes mellitus and atherosclerotic events in renal transplants recipients: a prospective study. Transplantation 2005; 79: 438.
4. Ducloux D, Deschamps M, Yannaraki M, et al. Relevance of Toll-Like Receptor-4 polymorphisms in renal transplantation. Kidney Int 2005; 67: 2454.
5. Heliö T, Halme L, Lappalainen M, et al. CARD15/NOD2 gene variants are associated with familially occuring and complicated forms of Crohn's disease. Gut 2003; 52: 558.
6. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002; 359: 1661.
7. Holler E, Rogler G, Herfarth H, et al. Both donor and recipient NOD2/ CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004; 104: 889.
8. Ogura Y, Inohara N, Benito A, et al. NOD2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001; 276: 4812.
9. Girardin SE, Boneca IG, Viala J, et al. NOD2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278: 8869.
10. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995; 92: 1355.
11. Ducloux D, Challier B, Saas P, et al. CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J Am Soc Nephrol 2003; 14: 767.
12. Philpott DJ, Girardin SE. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 2004; 41: 1099.
13. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1998; 2: 983.
14. Morré SA, Stooker W, Lagrand WK, et al. Microorganisms in the aetiology of atherosclerosis. J Clin Pathol 2000; 53: 647.
15. Grayston JT, Kronmal RA, Jackson LA, et al. Azithromycin for the secondary prevention of coronary events. N Engl J Med 2005; 352: 1637.
16. Cannon CP, Braunwald E, McCabe CH, et al. Antibiotic treatment of Chlamydiae pneumoniae after coronary syndrome. N Engl J Med 2005; 352: 1646.
17. Pauleau AL, Murray PJ. Role of NOD2 in the response of macrophages to Toll-like receptor agonists. Mol Cell Biol 2003; 23: 7531.
18. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptative immuniy in the intestinal tract. Science 2005; 307: 731.
19. Ogura Y, Lala S, Xin W, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003; 52: 1591.
20. Hill GR, Crawford JM, Cooke KR, et al. Total body irradiations effects on acute graft versus host disease. The role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204.